Patent · US Active

Fc-receptor binding modified asymmetric antibodies and methods of use

US12264196B2 · kind B2 · utility

0Cited by

10References

14Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Joerg Thomas Regula · Munich, DE
Wolfgang Schaefer · Sankt Augustin, DE
Tilman Schlothauer

Key dates

Filing date	Oct 2, 2019
Grant date	Apr 1, 2025
Priority date	—
Expiry date	Sep 1, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies and Fc-region fusion polypeptides which are asymmetrically modified with respect to their Fc-receptor, especially their FcRn, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.